Status:
UNKNOWN
Xanthine Oxidase and Uric Acid Origin in Preeclamptic Women
Lead Sponsor:
Barzilai Medical Center
Conditions:
Pre-Eclampsia
Hyperuricemia
Eligibility:
FEMALE
20-55 years
Brief Summary
Findings regarding the presence of xanthine oxidase and uric acid in different blood locations is important in preeclamptic women. We aim to detecting Xanthine oxidase and uric acid levels in both umb...
Detailed Description
Significance - findings regarding the presence of xanthine oxidase and uric acid in different blood locations may provide a scientific basis for understanding the source of them in preeclamptic women....
Eligibility Criteria
Inclusion
- preeclampsia and none-preeclampsia diagnosed pregnant women.
Exclusion
- Known or reported kidney disease.
Key Trial Info
Start Date :
June 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04463940
Start Date
June 30 2020
End Date
August 1 2024
Last Update
July 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barzilai Medical Center
Ashkelon, Israel, 78306